IBEX 3519.177,70▼ -0,28%EuroStoxx 506168,26▼ -0,36%S&P 5007719,69▲ +0,01%€/$1,1215▲ +0,52%Brent106,00▼ -0,06%Bitcoin73.176▲ +0,42%

Breaking

Anti-Corruption Agency Supports Aldama's Accusations Against Azvi PresidentThe Maricarmen Decree Complicates Access to Housing in MadridBill Gates warns about the dangers of uncontrolled AIMadrid celebrates the IV edition of 'La Noche del Deporte' with thousands of attendeesAndalusian industry invoices 9.4% more until July, double the national averageThe Government defends the Huelva-Sevilla train works and details 8 million in actions

Outlook Therapeutics

Latest Outlook Therapeutics news

2 articles

Primer plano de un frasco de colirio oftalmológico con un calendario borroso al fondo

Companies

Outlook Therapeutics: FDA to Decide on Eye Drug Lytenava on July 29

Outlook Therapeutics faces a pivotal July: shareholders vote on capital increase on the 16th and FDA decides on Lytenava on the 29th.

Beatriz Lorenzo Aguirre · 12 July 2026

Vial of medication on legal documents with a judge's gavel beside it, in a dimly lit boardroom

Companies

Outlook Therapeutics Faces a Decisive July Between the FDA and Capital Dilution

Outlook Therapeutics faces a crucial July: shareholder meeting for capital increase and FDA decision on its flagship drug. Shares rise 144% in 2026.

Beatriz Lorenzo Aguirre · 9 Jul 2026